正电子发射断层扫描（PET）在胆管癌中的应用。
Positron emission tomography (PET) for cholangiocarcinoma.
机构信息
Swiss HPB (Hepato-pancreato-Biliary) Center, Department of Surgery, University Hospital Zurich, Switzerland.
出版信息
HPB (Oxford). 2008;10(2):120-1. doi: 10.1080/13651820801992583.
Abstract
The combination of positron emission tomography (PET) with computed tomography (PET-CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. Sensitivity of PET/PET-CT is higher for intrahepatic (>90%) than for extrahepatic cholangiocarcinoma (CCA) (about 60%). The detection rate of distant metastasis is 100%. PET, and particularly PET-CT, improves the results and impacts on the oncological management in CCA compared with other imaging modalities. Therefore, PET-CT is recommended in the preoperative staging of intrahepatic (strength of recommendation: moderate) and extrahepatic (strength of recommendation: low) CCA.
摘要
正电子发射断层扫描（PET）与计算机断层扫描（PET-CT）相结合，可在同一次成像过程中同时提供肿瘤的代谢和解剖信息。PET/PET-CT 对肝内（>90%）比肝外胆管癌（CCA）（约 60%）的敏感性更高。远处转移的检出率为 100%。与其他影像学方法相比，PET 尤其是 PET-CT，可改善 CCA 的结果并影响肿瘤治疗管理。因此，推荐在肝内（推荐强度：中度）和肝外（推荐强度：低度）CCA 的术前分期中使用 PET-CT。
相似文献
1
Positron emission tomography (PET) for cholangiocarcinoma.
HPB (Oxford). 2008;10(2):120-1. doi: 10.1080/13651820801992583.
2
Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
J Investig Med. 2018 Jan;66(1):52-61. doi: 10.1136/jim-2017-000472. Epub 2017 Sep 14.
3
Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
Korean J Radiol. 2020 Dec;21(12):1355-1366. doi: 10.3348/kjr.2019.0891. Epub 2020 Aug 4.
4
Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model.
Clin Exp Pharmacol Physiol. 2015 Mar;42(3):293-304. doi: 10.1111/1440-1681.12354.
5
[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8. doi: 10.1097/01.rct.0000237811.88251.d7.
6
Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
J Hepatol. 2006 Jul;45(1):43-50. doi: 10.1016/j.jhep.2006.03.009. Epub 2006 Apr 19.
7
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Am J Gastroenterol. 2008 May;103(5):1145-51. doi: 10.1111/j.1572-0241.2007.01710.x. Epub 2008 Jan 2.
8
[Correlation between TNM staging of primary cholangiocarcinoma and the maximum standard uptake value of (18)F-2-deoxy-D-glucose positron emission tomography with computerized tomography].
Zhonghua Yi Xue Za Zhi. 2017 Oct 24;97(39):3104-3107. doi: 10.3760/cma.j.issn.0376-2491.2017.39.013.
9
(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis.
Asia Ocean J Nucl Med Biol. 2015 Winter;3(1):18-25.
10
Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
J Gastroenterol Hepatol. 2008 May;23(5):759-65. doi: 10.1111/j.1440-1746.2007.05173.x. Epub 2007 Oct 10.
引用本文的文献
1
Occupational and Environmental Cholangiocarcinoma-Related Toxic Exposures.
GE Port J Gastroenterol. 2024 Nov 7;32(3):151-160. doi: 10.1159/000541868. eCollection 2025 Jun.
2
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma.
World J Gastroenterol. 2024 Mar 7;30(9):1018-1042. doi: 10.3748/wjg.v30.i9.1018.
3
Locoregional Approaches in Cholangiocarcinoma Treatment.
Cancers (Basel). 2022 Nov 28;14(23):5853. doi: 10.3390/cancers14235853.
4
Multimodal molecular imaging evaluation for early diagnosis and prognosis of cholangiocarcinoma.
Insights Imaging. 2022 Jan 20;13(1):10. doi: 10.1186/s13244-021-01147-7.
5
Detection of Human Cholangiocarcinoma Markers in Serum Using Infrared Spectroscopy.
Cancers (Basel). 2021 Oct 12;13(20):5109. doi: 10.3390/cancers13205109.
6
Liver: glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases.
Am J Nucl Med Mol Imaging. 2021 Aug 15;11(4):233-249. eCollection 2021.
7
Management of Intrahepatic Cholangiocarcinoma.
J Clin Med. 2021 May 27;10(11):2368. doi: 10.3390/jcm10112368.
8
[Intrahepatic cholangiocarcinoma - current perspectives and treatment algorithm].
Chirurg. 2018 Nov;89(11):858-864. doi: 10.1007/s00104-018-0718-y.
9
[Treatment approach for gall bladder and extrahepatic bile duct cancer].
Chirurg. 2018 Nov;89(11):880-886. doi: 10.1007/s00104-018-0704-4.
10
Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the F-FDG PET/CT Findings.
Intern Med. 2017 Nov 15;56(22):3027-3031. doi: 10.2169/internalmedicine.8839-17. Epub 2017 Sep 25.
本文引用的文献
1
Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
J Gastroenterol Hepatol. 2008 May;23(5):759-65. doi: 10.1111/j.1440-1746.2007.05173.x. Epub 2007 Oct 10.
2
[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8. doi: 10.1097/01.rct.0000237811.88251.d7.
3
Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
J Hepatol. 2006 Jul;45(1):43-50. doi: 10.1016/j.jhep.2006.03.009. Epub 2006 Apr 19.
4
Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.
J Hepatobiliary Pancreat Surg. 2003;10(6):432-40. doi: 10.1007/s00534-002-0842-3.
5
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1467-72. doi: 10.1007/s00259-003-1297-8. Epub 2003 Aug 7.
6
PET diagnostic accuracy: improvement with in-line PET-CT system: initial results.
Radiology. 2002 Nov;225(2):575-81. doi: 10.1148/radiol.2252011568.
7
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1047-54. doi: 10.1007/s00259-002-0852-z. Epub 2002 Jun 1.
8
FDG PET in the diagnosis of hilar cholangiocarcinoma.
Nucl Med Commun. 2001 Dec;22(12):1277-85. doi: 10.1097/00006231-200112000-00002.
9
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
Hepatology. 2001 May;33(5):1029-35. doi: 10.1053/jhep.2001.23912.
10
Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.
Ann Surg. 2000 Oct;232(4):557-69. doi: 10.1097/00000658-200010000-00011.
Zotero 插件